Federal Appeals Court Rejects Hearing On Cox-2 Patent

Law360, New York (July 6, 2004, 12:00 AM EDT) -- The U.S. Court of Appeals for the Federal Circuit has denied the University of Rochester’s request for a hearing by the court’s full panel on the validity of a patent for cox-2 inhibitors such as Pfizer’s $3 billion Celebrex drug.

University of Rochester scientists claim they discovered the gene that produces the cox-2 enzyme and described the role it plays in producing inflammation and pain. Cox-2 inhibitors are drugs that can relieve pain and inflammation without causing cramps and bleeding.

The university applied for the patent...
To view the full article, register now.